Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance

Diabetes Care

Volumn 19, Issue 1, 1996, Pages 17-20

  Hanson, Ulf ^a,d   Persson, Bengt ^b   Hartling, Svend G ^c   Binder, Christian ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STENO DIABETES CENTER   (Denmark)

^d RSO   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREGNANCY DIABETES MELLITUS; RISK ASSESSMENT;

EID: 0030042474     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.1.17     Document Type: Article

References (15)

1. O'Sullivan JB: The Boston gestational diabetes studies: review and prospectives. In Carbohydrate Metabolism in Pregnancy and the Newborn. Sutherland HW, Stowers JM, Pearsson DWM, Eds. London, Springer-Verlag, London, 1989, p. 287-294
2. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowles WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproporaonally elevated proinsuhn in Pima Indians with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 70:1247-1253, 1990
3. Mako ME, Starr JIL, Rubenstein AH: Circulating proinsulin in patients with maturity onset diabetes Am J Med 63:865-896, 1977
4. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702, 1987
5. Persson B, Hanson U, Hartling SG, Binder C. Follow-up of women with previous GDM: insulin, C-peptide and proinsulin responses to oral glucose load. Diabetes 40 (Suppl. 2): 136-141, 1991
6. Persson B, Stangenberg M, Hanson U, Nordlander E: Gestational diabetes mellitus (GDM): comparative evaluation of two treatment regimens, diet versus insulin and diet Diabetes 34 (Suppl. 2):101-105, 1985
7. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser , no. 727)
8. Heding LG Determination of total serum insulin (IRI) in insulin-dependent diabetic patients. Diabetologia 8:260-266, 1972
9. Hartling SG, Dinesen B, Kappelgaard AM: ELISA for human proinsulin Clin Chim Acta 156:289-298, 1986
10. Kahn SE, Saad MF, Nelson RG, Pettitt DJ, Porte D Jr: Disproportionally elevated proinsulin levels are a feature of NIDDM in Pima Indians (Abstract). Clin Res 37: 131A, 1989
11. Porte D Jr, Kahn SE, Hyperproinsulinemia and amyloid in NIDDM. Diabetes 38 1333-1336, 1989
12. Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte D Jr: Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol 74:192-197, 1992
13. Levy JC, Clark PM, Hales N, Turner RC Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response. Diabetes 42:162-169, 1993
14. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 38, 1271-1274, 1989
15. Heaton DA, Millward BA, Gray P, Tun Y, Hales CN, Pyke DA, Leslie RDG: Evidence of β cell dysfunction which does not lead onto diabetes: a study of identical twins of insulin dependent diabetics. Br Med J 294: 145-146, 1987